FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1279-1280 April 29, 1993 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Wei is to be commended for her scholarly review of the effect of age on the cardiovascular system (Dec. 10 issue)¹. However, her recommendations for treating systolic dysfunction do not reflect the results of several studies documenting the beneficial effects of angiotensin-converting-enzyme inhibitors in patients with reduced systolic function.

The Cooperative North Scandinavian Enalapril Survival Study,² conducted among patients with a mean age of 71 years and severe congestive heart failure (New York Heart Association functional class IV), demonstrated decreased mortality among those given enalapril as compared with those given placebo. The Studies of Left Ventricular . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Sotos, J. G. (2003). Taft and Pickwick: Sleep Apnea in the White House. Chest 124: 1133-1142 [Abstract] [Full Text]  
• Rudkowski, J.C., Verschelden, P., Kimoff, R.J. (2001). Efficacy of daytime continuous positive airway pressure titration in severe obstructive sleep apnoea. Eur Respir J 18: 535-541 [Abstract] [Full Text]